Unique approach to treatment of rare and aggressive blood cancers

by Julia Short,Cardiff UniversityCredit: CC0 Public DomainA unique approach to targeting the abnormal T-cells that cause T-cell lymphomas could offer hope to patients with the aggressive and dif

Updated on: April 10,2024

Unique approach to treatment of rare and aggressive blood cancers

by Julia Short,Cardiff UniversityCredit: CC0 Public DomainA unique approach to targeting the abnormal T-cells that cause T-cell lymphomas could offer hope to patients with the aggressive and dif

Updated on:April 10,2024

Study may explain why some triple-negative breast cancers are resistant to chemotherapy

by University of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainTriple-negative breast cancer (TNBC) is an aggressive form of the disease accounting for 12 to 18 percent of breast can

Updated on: June 28,2024

Study may explain why some triple-negative breast cancers are resistant to chemotherapy

by University of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainTriple-negative breast cancer (TNBC) is an aggressive form of the disease accounting for 12 to 18 percent of breast can

Updated on:June 28,2024

New international exercise guidelines for cancer survivors

by Kerry Blackadar,University of British ColumbiaDr. Kristin Campbell (left), associate professor at UBC's department of physical therapy, with former BC Cancer patient Scenery Slater. Credi

Updated on: April 14,2024

New international exercise guidelines for cancer survivors

by Kerry Blackadar,University of British ColumbiaDr. Kristin Campbell (left), associate professor at UBC's department of physical therapy, with former BC Cancer patient Scenery Slater. Credi

Updated on:April 14,2024

Researchers program cancer-fighting cells to resist exhaustion, attack solid tumors in mice

by Stanford University Medical CenterCredit: CC0 Public DomainA new approach to programing cancer-fighting immune cells called CAR-T cells can prolong their activity and increase their effectiven

Updated on: June 24,2024

Researchers program cancer-fighting cells to resist exhaustion, attack solid tumors in mice

by Stanford University Medical CenterCredit: CC0 Public DomainA new approach to programing cancer-fighting immune cells called CAR-T cells can prolong their activity and increase their effectiven

Updated on:June 24,2024

Researchers determine oral bacteria accelerate pancreatic cancer development in mice

by Hebrew University of JerusalemPancreas sections from control and P.gingivalis-infected mice. Control mouse showing a small pre-cancerous lesion (marked in yellow). Credit: Hebrew University of

Updated on: March 30,2024

Researchers determine oral bacteria accelerate pancreatic cancer development in mice

by Hebrew University of JerusalemPancreas sections from control and P.gingivalis-infected mice. Control mouse showing a small pre-cancerous lesion (marked in yellow). Credit: Hebrew University of

Updated on:March 30,2024

Discovery of a new tumor cell type in childhood cancer

byKarolinska InstitutetMulti-omic CNV identification in single neuroblastoma cells reveal complex subclonal architectures and identify abnormal SCP-like populations carrying whole-chromosome gai

Updated on: September 30,2024

Discovery of a new tumor cell type in childhood cancer

byKarolinska InstitutetMulti-omic CNV identification in single neuroblastoma cells reveal complex subclonal architectures and identify abnormal SCP-like populations carrying whole-chromosome gai

Updated on:September 30,2024

Study shows promising results for immunotherapy targeting skin cancer

by King's College LondonCSPG4 expression in malignant melanoma and normal tissues.aCSPG4 mRNA expression, derived from RNAseq data, across cell lines of different cancer cell type

Updated on: February 20,2024

Study shows promising results for immunotherapy targeting skin cancer

by King's College LondonCSPG4 expression in malignant melanoma and normal tissues.aCSPG4 mRNA expression, derived from RNAseq data, across cell lines of different cancer cell type

Updated on:February 20,2024

Efficient removal of abnormal myelin allows survival of nerve fibers targeted by adaptive immune cells

by Julius-Maximilians-Universität WürzburgElectronmicroscopic pictures of white matter axons in healthy control mice (top) and mice with different myelin gene defects. Axons that remain wrapped w

Updated on: May 11,2024

Efficient removal of abnormal myelin allows survival of nerve fibers targeted by adaptive immune cells

by Julius-Maximilians-Universität WürzburgElectronmicroscopic pictures of white matter axons in healthy control mice (top) and mice with different myelin gene defects. Axons that remain wrapped w

Updated on:May 11,2024

Study pinpoints origin of pediatric brain tumor type and shows it may be preventable

by The Hospital for Sick ChildrenCredit: Unsplash/CC0 Public DomainAn aggressive type of pediatric brain tumor, medulloblastoma, exists in a pre-malignant form at birth after initially developing duri

Updated on: February 18,2024

Study pinpoints origin of pediatric brain tumor type and shows it may be preventable

by The Hospital for Sick ChildrenCredit: Unsplash/CC0 Public DomainAn aggressive type of pediatric brain tumor, medulloblastoma, exists in a pre-malignant form at birth after initially developing duri

Updated on:February 18,2024

Targeting LTA4H improves the tumor immune microenvironment in ovarian cancer: Study

by Science China PressKnockdown of LTA4H resulted in an attenuated tumor growth and ascites formation. Flow cytometry results showed significantly increased ratio of M1 to M2 macrophages and perc

Updated on: March 20,2024

Targeting LTA4H improves the tumor immune microenvironment in ovarian cancer: Study

by Science China PressKnockdown of LTA4H resulted in an attenuated tumor growth and ascites formation. Flow cytometry results showed significantly increased ratio of M1 to M2 macrophages and perc

Updated on:March 20,2024

BRAF inhibitor shows promising results in pediatric patients with low-grade glioma

by American Association for Cancer ResearchGlioma of the left parietal lobe. CT scan with contrast enhancement. Credit: Mikhail Kalinin/CC BY-SA 3.0Dabrafenib (Tafinlar), a BRAF inhibitor approve

Updated on: March 30,2024

BRAF inhibitor shows promising results in pediatric patients with low-grade glioma

by American Association for Cancer ResearchGlioma of the left parietal lobe. CT scan with contrast enhancement. Credit: Mikhail Kalinin/CC BY-SA 3.0Dabrafenib (Tafinlar), a BRAF inhibitor approve

Updated on:March 30,2024

New computational approach increases accessibility to single-cell tumor profiling to improve treatment outcomes

by Ana María Rodríguez, Ph.D.,Baylor College of MedicineCredit:Genome Biology(2023). DOI: 10.1186/s13059-023-03016-6To improve therapies for cancer and other diseases, researchers st

Updated on: January 12,2024

New computational approach increases accessibility to single-cell tumor profiling to improve treatment outcomes

by Ana María Rodríguez, Ph.D.,Baylor College of MedicineCredit:Genome Biology(2023). DOI: 10.1186/s13059-023-03016-6To improve therapies for cancer and other diseases, researchers st

Updated on:January 12,2024